Please assess the completion status of the following clinical trial:

Trial Title: Effect of Nasaleze on Nasal Challenge With Allergen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~1. Males and females between 18 and 45 years of age.~2. History of grass and/or ragweed allergic rhinitis.~3. Positive skin test to grass and/or ragweed antigen.~4. Positive response to screening nasal challenge.~Exclusion Criteria:~1. Physical signs or symptoms suggestive of renal, hepatic or cardiovascular disease.~2. Pregnant or lactating women.~3. Upper respiratory infection within 14 days of study start.~4. FEV1\<80% of predicted at screening for subjects with history of mild asthma.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- Nasaleze spray (Type: ACTIVE_COMPARATOR): Nasaleze spray 1 puff via spray device in each nostril 3 times daily for 1 week followed by allergen challenge
- Placebo spray (Type: PLACEBO_COMPARATOR): Placebo spray 1 puff via spray device in each nostril 3 times daily for 1 week followed by allergen challenge

Based on this trial design, predict the completion outcome and termination type (if applicable).